CRH changes
Pick any two versions below to diff them.
- Price
- $90.81 → $96.26(+6.0%)
- Recent events
- added: Nov 9, 2026: CRH sold $4.2 billion of guaranteed notes: $1.35 billion of 5.375% notes due 2032, $1.0 billion of 5.625% notes due 2034, $1.35 billion of 5.750% notes due 2037 and $500 million of 6.250% notes due 2057. It plans to use the money for tender offers for Arcosa's notes, to repay debt and for general corporate purposes. Oct 29, 2026: CRH reported Q3 2026 results. Total revenues rose 3% to $11.4 billion, adjusted EBITDA was flat at $2.7 billion, and net income fell 22% to $1.2 billion, mainly because of a $178 million impairment in the Philippines. CRH cut its 2026 guidance to net income of $3.1 billion to $3.3 billion and adjusted EBITDA of $7.8 billion to $8.0 billion, from $3.9 billion to $4.1 billion and $8.1 billion to $8.5 billion. It gave cost inflation and a weaker residential market as reasons, and the new guidance includes Arcosa. The board approved a new share buyback of up to $6 billion to the end of 2030. Oct 29, 2026: CRH started Velocity, a two-year program to simplify its operating model. It expects yearly run-rate benefits of about $400 million by the end of 2028 and one-time costs of about $400 million. Oct 23, 2026: CRH completed the purchase of Arcosa for an enterprise value of about $8.5 billion, earlier than the Q1 2027 date that it expected. It paid with a $2.5 billion term loan, a $3.3 billion bridge facility and cash. Sep 4, 2026: Arcosa stockholders approved the purchase by CRH at a special meeting. About 99.8% of the votes cast were for the deal. The deal still needs regulatory approvals, and CRH and Arcosa expect it to close in Q1 2027. Jul 30, 2026: CRH reported Q2 2026 results. Total revenues rose 6% to $10.8 billion, net income rose 13% to $1.5 billion, and adjusted EBITDA rose 7% to $2.6 billion. CRH sold three non-core businesses for about $1.9 billion in total and bought Axius Water for $0.7 billion. It reaffirmed its 2026 guidance and raised the quarterly dividend 5% to $0.39. Jul 17, 2026: CRH signed a three-year $2.5 billion term loan facility for the Arcosa purchase, which reduced the commitments under its bridge facility to $3.25 billion. Jun 22, 2026: CRH agreed to buy Arcosa for $150 per share in cash, an enterprise value of about $8.5 billion, or 11.5 times 2026 estimated adjusted EBITDA including $175 million of expected cost synergies. CRH expects the deal to close in Q1 2027, subject to Arcosa stockholder and regulatory approvals, and expects pro forma net debt to adjusted EBITDA of 2.4 times for 2026. May 11, 2026: CRH appointed Aylwyn Bryan as Chief Financial Officer, effective May 12, 2026. He replaced Nancy Buese, who stepped down by mutual agreement.